ArticleBMC immunology2024

TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation.

Yosuke Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.